We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Ronald Ifraimov
Ronald Ifraimov
Products
PRODUCTS
Maxxion Technology, LLC
Ronald Ifraimov
Price:
$117.00
View
Uspharma, Ltd.
Ronald Ifraimov
Price:
$117.00
View
US Infusion, Inc.
Ronald Ifraimov
Price:
$117.00
View
Silq Technologies Corp.
Ronald Ifraimov
Price:
$117.00
View
Lummacups, LLC
Ronald Ifraimov
Price:
$117.00
View
Guard Medical, Inc.
Ronald Ifraimov
Price:
$117.00
View
Natech Plastics, Inc.
Ronald Ifraimov
Price:
$117.00
View
DuoProSS Meditech Corp.
Ronald Ifraimov
Price:
$117.00
View
Kem Medical Products Corp.
Ronald Ifraimov
Price:
$117.00
View
Wound Healing Technologies
Ronald Ifraimov
Price:
$117.00
View
View All Products by Ronald Ifraimov
Upcoming Events
25
Apr
A Masterclass on Effective 483 Responses
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
30
May
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
Form 483 With OAI Issued to Sun Pharma’s Dadra Plant
3-D Printed Cranial Implant Gets 510(k) Clearance
Kickback Suit for Allergan’s Promotion of Botox for Pediatric Migraine Upheld by Judge
New Portal Allows Public to Report Anticompetitive Healthcare Practices
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More